Loperamide reverses 5‑FU resistance in colorectal cancer by activating autophagy
Oncology Reports · 2025
DOI: 10.3892/or.2025.8966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Juan Yu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China. Hauptthemen laut MEDLINE: Fluorouracil, Colorectal Neoplasms, Autophagy, Drug Resistance, Neoplasm. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
- Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
- Shiyan Key Laboratory of Virology, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
Zitieren
APA
Yu, J., An, X., Qu, X., Ke, J., Rao, H., Liu, Y., Liu, Z., Liu, D., Jia, J., & Li, S. (2025). Loperamide reverses 5‑FU resistance in colorectal cancer by activating autophagy. Oncology Reports. https://doi.org/10.3892/or.2025.8966
Vancouver
Yu J, An X, Qu X, Ke J, Rao H, Liu Y, et al. Loperamide reverses 5‑FU resistance in colorectal cancer by activating autophagy. Oncology Reports. 2025. doi:10.3892/or.2025.8966
BibTeX
@article{Yu2025,
author = {Yu, Juan and An, Xiaotong and Qu, Xinyang and Ke, Jing and Rao, Huiling and Liu, Yang and Liu, Zhixin and Liu, Danwen and Jia, Jie and Li, Shan},
title = {Loperamide reverses 5‑FU resistance in colorectal cancer by activating autophagy},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.8966}
}
EUVIMED